Position in SPRY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$4,862,382
+$3,172,870 QoQ
Shares Held
607,039
+188.5% QoQ
Ownership
0.610%
of shares outstanding
% of Portfolio
2.00%
of 13F equity value
Holder Rank
#20
of 208 holders
Holding Since
Dec 2022
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SPRY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tejara Capital Ltd holds $21,229,968 across 5 Biotechnology names. SPRY ranks #2 (22.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
1,595,345 | $9,954,952 | |
| 2 | SPRY |
ARS Pharmaceuticals, Inc.
This page
|
607,039 | $4,862,382 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
113,084 | $2,965,062 | |
| 4 | HRTX |
Heron Therapeutics, Inc. /De/
|
6,510,795 | $2,799,641 | |
| 5 | MREO |
Mereo BioPharma Group plc
|
2,037,520 | $647,931 |
All Filings in SPRY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,862,382 | 607,039 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $1,689,512 | 210,400 | Shares | Sole | 2026-05-12 | |
| 2023-12-31 | $404,089 | 73,739 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $392,133 | 103,739 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $894,590 | 133,521 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,351,183 | 207,555 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $296,460 | 34,755 | Shares | Sole | 2023-02-15 | |
| No filing history on record for this holder in this stock. | ||||||